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BACKGROUND/PURPOSE: Infectious endocarditis (IE) is a rare, but potentially fatal disease in pediatric 
patients. In this study, we reviewed the symptoms and signs, etiology, laboratory findings and outcomes 
of IE patients over the past 10 years.
METHODS: Patients (< 18 years old) with definite IE according to the modified Duke criteria, or patients 
with positive pathological findings, between September 1998 and September 2008 were included in 
the study. The etiology, symptoms and signs, laboratory findings and outcomes were collected via chart 
review.
RESULTS: Nineteen cases (13 boys and 6 girls) ranging in age from 2.5 months to 18 years (mean = 7.98 
years; median = 5 years) were included. Nine out of 17 cases (52.9%) had microscopic hematuria and two 
out of three (66.7%) cases showed elevated rheumatoid factor levels. Seventeen (89.5%) had fever and seven 
(36.8%) had major vessel embolic events. Blood cultures yielded Staphylococcus aureus in seven cases, and 
viridans Streptococci in two cases. The other three cases had Pneumococcus, Pseudomonas aeruginosa and 
Candida albicans. Two patients died and one was discharged in a critical condition. Two of the seven (28.6%) 
patients with a positive blood culture for S. aureus died, three (42.9%) had an embolic event and one (14.3%) 
had central nervous system complications (intracranial hemorrhage). The initial C-reactive protein levels 
in the blood culture-positive group were significantly higher than those in the blood culture-negative 
group (p = 0.035). 
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Introduction
Infectious endocarditis (IE) is a rare, but potentially fatal 
disease in pediatric patients. Most patients have under-
lying hemodynamic problems that predispose them to 
the risks of IE. Modified Duke criteria are commonly used 
for clinical diagnosis of IE.1 Though Streptococcus viridans 
and Staphylococcus aureus are the main pathogens of the 
disease, other pathogens have also been isolated.2–4 In this 
study we reviewed the symptoms and signs, etiologies, 
laboratory findings and outcomes of pediatric IE patients 
over the past 10 years and the initial white blood cell 
counts (WBC) and C-reactive protein (CRP) levels were 
recorded.
Methods
Patients less than 18 years of age who fulfilled the criteria 
of definite IE according to the modified Duke criteria, 
or cases with positive pathological findings, from 
September 1998 to September 2008 were retrospectively 
included in the chart review study. Echocardiography 
findings were confirmed by experienced cardiologists 
(> 10 years’ experience), except for one case in which 
the sternum was left unapproximated. Data regarding 
etiology, general patient characteristics and underlying 
diseases, symptoms and signs, sites of vegetation, labora-
tory findings and outcomes were collected. The WBC 
counts and CRP levels (taken at first presentation at the 
hospital) of culture-positive and culture-negative patients 
and between S. aureus and non-S. aureus groups were 
compared using the Mann-Whitney U test and SPSS ver-
sion 14.0 (SPSS, Chicago, IL, USA). Risk factors for mor-
tality (e.g. neurological complications, gender, embolic 
events and IE pathogens) and embolic events (S. aureus 
infections) were investigated for statistical significance 
using Fisher’s exact test. A p value < 0.05 was considered 
statistically significant. 
Results
General characteristics
In all, 19 cases (13 boys and 6 girls) were included in the 
study. All cases fulfilled the criteria of definite endocardi-
tis according to the modified Duke criteria, or were path-
ologically confirmed. The age of the patients ranged from 
2.5 months to 18 years (mean = 7.98 years, median = 
5 years). The age and gender distributions are shown in 
Figure 1. Five cases (26.3%) were immunocompromised 
and without a previous history of heart disease. Of the 14 
cases with congenital heart disease, 11 cases (78.6%) had 
undergone previous cardiac surgery and all had residual 
heart abnormalities with a turbulent flow. Of the 11 cases 
with congenital heart disease post-surgery, the time be-
tween the last operation and the onset of endocarditis 
ranged from 1 month to 12 years (mean = 39.5 months; 
median = 12 months) (Table 1). The most common sites 
of vegetation were the tricuspid valve (7 cases), the right 
ventricle (6 cases) and the mitral valve (4 cases). There was 
no obvious trend in the number of cases per year over the 
past 10 years (Figure 2) or seasonal changes (Figure 3).
Findings on presentation
The major presenting symptoms and signs are summa-
rized in Table 2. Seventeen patients (89.5%) had fever and 
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Figure 1. Age distribution of 19 patients with infectious endocarditis.
CONCLUSION: S. aureus is one of the most common etiologies in IE patients, while viridans Streptococcus 
accounts for fewer cases than suggested by previous studies. IE caused by S. aureus seems to carry a higher 
risk of mortality, and embolic events are associated with increased mortality.
KEYWORDS: child, echocardiogram, etiology, infectious endocarditis, laboratory findings
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Table 1. The sites of vegegations, C-reactive protein levels at diagnosis of infectious endocarditis and blood culture results and 
duration between onset of infectious endocarditis and last operations
Case Site of vegetations
 Duration between  Blood culture CRP at diagnosis
  IE and operation results of IE (mg/dL)
 1 Poor visualization 9 mo MRSA 9.81
 2 RV, TV 7 yr MSSA 24.91
 3 TV  5 yr & 4 mo Viridan Streptococci 2.58
 4 PV  5 yr – 5.27
 5 MV 2 mo – 0.06
 6 LV, AV 1 mo MRSA 21.29
 7 –  1 mo Pseudomonas aeruginosa 1.05
 8 RV  11 yr – 1.66
 9 RV, RA 9 mo – 0.58
10 RV, TV 5 yr – 9.59
11 TV  1 yr Pneumococcus 2.40
12 RV, AO, MV – MRSA 17.30
13 TV  – MSSA 20.70
14 RV, VSD – Viridan Streptococci 0.30
15 RA  – Candida Albican 18.20
16 TV  – MSSA 1.60
17 MV, TV – MRSA 2.60
18 AV  – – 0.01
19 MV – – 0.90
CRP = C-reactive protein; RV = right ventricle; LV = left ventricle; PV = pulmonary valve; AV = aortic valve; MV = mitral valve; TV = tricuspid valve; 
AO = aorta; RA = right atrium; VSD = ventricular septum defect; IE = infectious endocarditis; MRSA = methicillin-resistant Staphylococcus aureus; 
MSSA = methicillin-sensitive Staphylococcus aureus.
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Figure 2. The number of cases of infectious endocarditis 
(1998–2008).
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Figure 3. The number of cases of infectious endocarditis each 
month (1998–2008).
17 (94.4%) had documented vegetations via echocardio-
gram (2 patients did not have an echocardiogram and 
were diagnosed with definite IE on the basis of culture 
results and 3 additional minor criteria). Fever and vege-
tations were the most common initial presentations. Of 
the 17 cases who had routine urine tests, nine (52.9%) 
had evidence of microscopic hematuria. Seven patients 
(36.8%) had major vessel embolic events (1 intracranial 
hemorrhagic infarct, 1 brain abscess, 1 cerebral embolism, 
1 ischemic bowel, and 3 pulmonary embolisms above the 
intermediate level). Three patients were tested for Rheumatic 
factor and two (66.7%) of them had elevated levels. Four 
patients (21.1%) had Janeway’s lesions and one (5.3%) had 
ruptured chordae tendineae. Of the 16 cases who had a 
chest X ray, three (18.8%) had marked cardiomegaly. 
When the initial CRP levels in blood culture-positive and 
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blood culture-negative groups were compared, the blood 
culture-positive group (CRP = 10.27 ± 9.58 mg/dL) had 
significantly higher initial CRP levels than the culture-
negaive group (CRP = 2.58 ± 3.58; p = 0.035) (Table 1). How-
ever, there were no significant differences in the initial 
CRP levels and WBC counts between the S. aureus and 
non-S. aureus groups.
Underlying conditions
All cases had either underlying heart disease or were im-
munocompromised. Postoperative congenital heart dis-
ease was the most common underlying condition (11/19; 
57.9%). Five patients (26.3%) were immunocompromised 
(1 brain sarcoma with neutropenic fever, 2 osteomyelitis, 
1 neonatal pneumonia and 1 toxic megacolon under total 
parenteral nutrition with a central venous line infection). 
Three patients had congenital heart disease without sur-
gery (1 had a ventricular septal defect, 1 had severe mitral 
regurgitation with mitral valve prolapse, 1 patient with 
dental caries had transposition of the great arteries, with 
a single ventricle and atrium). Three patients had docu-
mented central line infections (1 brain sarcoma with 
Table 2. Presenting findings in 19 patients with infectious 
endocarditisa
Presenting findings n (%)
TTE prove 17/18 (94.4)
Fever 17/19 (89.5)
Microscopic hematuria 9/17 (52.9)
Janeway’s lesion 4/19 (21.1)
Pulmonary embolism 3/16 (18.8)
New cardiomegaly on plain films 3/19 (15.8)
Elevated RF levels 2/3 (66.7)
Acute renal failure 2/19 (10.5)
Shortness of breath 2/19 (10.5)
Brain infarct 1/19 (5.3)
Intracranial hemorrhage 1/19 (5.3)
Brain abscess 1/19 (5.3)
Bowel infarct 1/19 (5.3)
Rupture of cordae tendinae 1/19 (5.3)
Hepatitis 1/19 (5.3)
Syncope 1/19 (5.3)
aData presented as number of positive cases/total number of cases 
studied (%). TTE = transthoracic echocardiogram; RF = rheumatoid 
factor.
Table 3. Underlying conditions in 19 patients with infectious 
endocarditis
Case Diagnosis before infectious endocarditis
1 TGA post total correction
2 DORV post correction
3 TGA post Rastelli procedure
4 TGA post Mustard procedure, caries
5 MR post annuloplasty
6 TGA post total correction
7 DORV post correction, central line infection
8 TGA post PAB, BAS + large VSD
9 TOF post total correction
10 TOF post total correction, caries
11 TGA post total correction
12 Brain sarcoma, neutropenic fever, central line infection
13 Osteomyelitis, cerebral palsy
14 VSD
15 Toxic megacolon with central line infection
16 Osteomyelitis, motorcycle accident
17 Neonatal pneumonia
18 TGA with single ventricle and atrium, caries
19 MR
PAB = pulmonary artery banding; BAS = balloon atrial septectomy; 
VSD = ventricular septal defect; TGA = tranposition of great arteries; 
TOF = Tetralogy of Fallot; DORV = double outlet of right ventricle; 
MR = mitral regurgitation.
neutropenic fever, 1 toxic megacolon and 1 ventricular septal 
defect) and three had dental caries (1 Tetralogy of Fallot 
post-total correction, 1 transposition of the great arteries 
post-mustard operation and 1 single ventricle) (Table 3). 
Microbiological findings
Of the 19 cases that fulfilled the criteria of definite endo-
carditis according to the modified Duke criteria, 12 had 
positive blood culture results. Seven patients (36.8%) had 
S. aureus (4 methicillin-resistant S. aureus and 3 methicillin-
sensitive S. aureus), two (10.5%) had viridans Streptococci, one 
(5.3%) had Pneumococcus, one (5.3%) had Pseudomonas aeru-
ginosa, and one (5.3%) had Candida albicans (Table 4). The 
culture-negative patients were diagnosed with definite IE by 
echocardiogram and three additional minor criteria, except 
one patient in whom IE was diagnosed pathologically. 
Three out of seven culture-negative patients lived in rural 
areas, but no history of animal contact was documented and 
four of the seven culture-negative patients were referred 
434
H.H. Wei, et al
from other hospitals. Five immunocompromised patients all 
had positive blood cultures (2 methicillin-resistant S. aureus, 
2 methicillin-sensitive S. aureus and 1 Candida albicans).
Patient outcomes
Two patients died and one was discharged in a critical 
condition, accounting for 15.8% of all cases included 
in the study. Two of the deceased patients (66.7%) were 
infected with S. aureus (1 methicillin-resistant and 1 
methicillin-sensitive) and one had negative blood culture 
results. All had either a pulmonary embolism, intracranial 
hemorrhage or a brain abscess. IE caused by S. aureus was 
not a statistically significant risk factor for mortality 
(p = 0.47; Fisher’s exact test). The three deceased patients 
were male, although male gender was not a statistically 
significant risk factor for mortality (p = 0.517; Fisher’s 
exact test), and two had neurological complications, al-
though neurological complications were not a statisti-
cally significant risk factor for mortality (p = 0.051; 
Fisher’s exact test). One of the patients died of sepsis and 
multiple organ failure, and another died of sepsis and 
brain herniation. Three out of seven cases with S. aureus 
infection had embolic events, but S. aureus infection was 
not a statistically significant risk factor for embolic events 
(p = 0.205; Fisher’s exact test). The embolic event rate was 
higher in the mortality group (100% vs. 25%; p = 0.036, 
Fisher’s exact test). One of the pulmonary embolisms was 
treated with antibiotics plus Coumadin and the result 
was favorable. The other two cases of pulmonary embo-
lism were treated with antibiotics only and one death oc-
curred. Three patients with IE underwent surgery with no 
mortality. None of the surviving patients has had a recur-
rence of definite IE to date.
Table 4. Microbiology findings in 19 patients with infectious 
endocarditis
Microbiology findings n (%)
Methicillin-resistent Staphylococcus aureus 4 (21.1)
Methicillin-sensitive Staphylococcus aureus 3 (15.8)
Viridan streptococci 2 (10.5)
Pneumococcus 1 (5.3)
Pseudomonas aeruginosa 1 (5.3)
Candida albican 1 (5.3)
Unknown 7 (36.8)
Discussion
The precise incidence of IE in pediatric patients is diffi-
cult to ascertain because case definitions have varied from 
decade to decade, between different authors, and between 
different medical centers.5 In one report, 50–70% of 
children less than 2 years old had no obvious underlying 
cardiac disease.6 However, two studies show that approxi-
mately 3/4 of patients with IE had a pre-existing struc-
tural cardiac abnormality, and another earlier study 
showed that rheumatic heart diseases accounted for 39% 
of heart abnormalities in IE.7–9 In our study, 73.7% (14/17) 
of patients had a heart structural abnormality, but none 
had rheumatic heart disease or a previous history of IE. 
This is in contrast to other studies that show recurrence 
of endocarditis accounting for 2.5–9.0% of IE cases.10,11 
The reason that rheumatic heart disease was seen less 
frequently in our study of pediatric IE may be largely due 
to the use of penicillin for primary prevention and im-
proved living conditions, which have resulted in less over-
crowding and better hygiene, and consequent reductions 
in transmission of group A Streptococci.12 Changes in the 
virulence of circulating group A Streptococci (i.e. a decrease 
in the prevalence of highly rheumatogenic emm-type 
group A Streptococci) have also accounted for much of the 
decline in the incidence of rheumatic fever, and approxi-
mately 95% of the reduction in the rate of death due to 
rheumatic fever during the 20th century in the United 
States occurred before 1960, probably because of reduced 
group A streptococcal transmission resulting from an im-
proved housing infrastructure.13 In Taiwan, the preva-
lence of rheumatic heart disease among school children 
was the highest in 1970 (1.42%) and in 1971 (1.26%), fall-
ing back to 0.39% in 1987. The prevalence suddenly rose 
to 0.7% in 1988, indicating a resurgence of rheumatic 
fever, followed by a steady decrease until 1997.14 The fact 
that none of our patients had a recurrence of IE might re-
flect the fact that they are just too young or that this 
study was conducted with small patient numbers and the 
follow-ups were not long enough.
The International Collaboration on Endocarditis-
Prospective Cohort Study identified the microbiological 
etiology in 1,779 patients from 39 medical centers in 16 
countries with definite endocarditis according to the 
Duke criteria.15 Overall, Staphylococci were the causal agent 
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in 744/1,779 (41.8%) of cases and Streptococci in 712 (40.0%). 
Eight percent of cases were culture-negative endocarditis 
and 1% were polymicrobial. However, a study conducted 
in Taiwan16 showed that S. aureus (32%) and streptococcal 
species (61%) were the most common causative patho-
gens. Also, male gender, heart failure, neurologic compli-
cations, renal insufficiency, respiratory failure, shock and 
Staphylococcus spp. as the causative microorganism, were 
all independent predictors of in-hospital mortality. 
Neurological complications was also found to be associ-
ated with higher mortality in other studies conducted in 
Taiwan.17,18 In our study, Staphylococci account for 36.8% 
and Streptococci for only 10% cases of endocarditis. Only 
embolic events were associated with higher mortality. In 
our study, four out of nine referred cases had culture-
negative IE compared with three of 10 non-referred cases. 
However, this was not statically significant (p = 0.65); 
36.8% were culture-negative IE, which is much higher 
than that reported in another study in Taiwan,19 which 
may reflect the overuse of antibiotics in pediatric patients 
and an insufficient number of blood samples collected.
The proportion of IE cases without an etiologic diag-
nosis varies from country to country and between differ-
ent centers in the same country. These variations reflect 
the local epidemiology of IE, the diagnostic criteria used, 
initiation of antibiotics in patients prior to obtaining 
blood cultures, and the diagnostic protocol used to estab-
lish an etiolog.20 The incidence of culture-negative IE is 
higher in developing countries and tends to occur more 
often with prosthetic valves,21–29 and mortality rates are 
similar between the culture-negative and culture-positive 
groups.29 Cultures remain negative in 2–7% of patients 
with IE, even when the utmost care is taken to obtain the 
proper number and volume of blood cultures and pa-
tients with prior antibiotic treatment are excluded; the 
frequency of culture-negative IE is higher in patients who 
have already been treated with antibiotics.30 Cultures can 
be negative in endocarditis patients for three major rea-
sons: (1) previous administration of antimicrobial agents; 
(2) inadequate microbiological techniques; or (3) infec-
tion with highly fastidious bacteria or nonbacterial path-
ogens (e.g. fungi). The higher frequency of culture-negative 
IE seen in developing countries reflects the increased inci-
dence of fastidious zoonotic agents (e.g. Bartonella spp., 
Coxiella burnetii, or Brucella spp.) that cause human 
infections,23 differences in microbiologic culture tech-
niques, and the overuse of antibiotics without prescrip-
tion in some countries.
The HACEK organisms (Haemophilus aphrophilus, Actino-
bacillus actinomycetemcomitans, Cardiobacterium hominis, 
Eikenella corrodens, and Kingella kingae) were thought to be 
the most common agents involved in culture-negative en-
docarditis. However, studies have found that the HACEK 
organisms can be isolated using current blood culture 
systems when incubated for at least 5 days.31,32 The mean 
and median durations of detection of HACEK pathogens 
from blood cultures were found to be 3.4 and 3 days, re-
spectively.33 The most common causative agents of blood 
culture-negative IE are fastidious organisms (e.g. zoonotic 
agents and fungi) and streptococcal spp. in patients who 
have received previous antibiotic treatment. Perhaps stud-
ies should be conducted that include serological tests 
for Coxiella burnetii, Bartonella spp., Chlamydo phila spp., 
Le ionella spp., and Aspergillus spp., using blood culture on 
shell vials and direct PCR amplification and lysis centrifu-
gation33–35 in cases of culture-negative IE to increase etiol-
ogy yields. Another reason for the larger portion of 
culture-negative IE found in our study (36.8%), apart 
from antibiotic overuse, might be that an insufficient 
blood volume was collected. In one study, blood cultures 
inoculated with at least 5 mL of blood had a significantly 
higher detection rate for bacteremia than bottles inocu-
lated with less than 5 mL of blood (92% vs. 69%).36 A mini-
mum of 0.5–5 mL of blood should be obtained from 
infants and children.37
In an analysis of native valve IE, 34% of patients had IE 
caused by S. aureus,38 while in our study S. aureus ac-
counted for 36.8%. Compared with patients with IE due 
to other organisms in a previous study,38 patients with S. 
aureus IE were significantly more likely to die (20% vs. 12%), 
experience an embolic event (60% vs. 31%), or have a CNS 
event (20% vs. 13%). In our study, 28.6% of cases (2/7) with 
positive culture for S. aureus died, 42.9% (3/7) had an em-
bolic event, and 14.2% (1/7) had a CNS complication (in-
tracranial hemorrhage), whereas no deaths, embolic 
events, or CNS complications occurred in the culture-
positive group that were caused by pathogens other than 
S. aureus. The risk of embolization tends to decline after 
the institution of effective antimicrobial therapy, and se-
rious embolic events rarely occur in the several weeks after 
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such therapy is instituted.39–41 In patients receiving ap-
propriate antibiotic therapy, the incidence of stroke was 
4.8/1,000 patient days in the first week of therapy, falling 
to 1.7/1,000 patient days in the second week, and contin-
uing to fall with continued therapy.41
In conclusion, IE carries a risk of mortality of 15.8% 
and IE caused by S. aureus accounted for 67% of deaths in 
our study. IE caused by S. aureus may also carry a higher 
risk of embolic events. Embolic events were associated 
with higher mortality. The decreased frequency of IE 
caused by viridans Streptococci (only 10.5%) may reflect the 
overuse of antibiotics and an insufficient number of 
blood samples. Proper blood culture collection (enough 
blood samples) and judicious use of antibiotics may in-
crease the yield of culture results. When culture-negative 
IE is encountered, blood culture on shell vials, direct PCR 
amplification, lysis centrifugation and serology tests may 
be considered to confirm an etiology.
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